physIQ Heart Rhythm and Respiratory Module vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

physIQ Heart Rhythm and Respiratory Module

by physIQ

ElucidVivo A.3

by Elucid

AI Verdict

Tool A focuses on continuous, real-time physiological monitoring using wearable biosensor data to detect subtle changes in heart rhythm and respiration. In contrast, Tool B is an AI-powered medical image analysis system that quantifies arterial plaque composition from CT angiography for atherosclerosis patient stratification. While both contribute to cardiovascular care, their distinct data sources and applications mean they address different clinical needs.

Choose physIQ Heart Rhythm and Respiratory Module if…

Choose physIQ Heart Rhythm and Respiratory Module if your primary need is continuous, real-time remote monitoring of patient physiological data from wearable biosensors. This tool is ideal for detecting subtle, personalized changes in heart rhythm and respiration, enabling early intervention for conditions like atrial fibrillation or respiratory decompensation in chronic disease management.

View physIQ Heart Rhythm and Respiratory Module →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if you require advanced, AI-powered quantitative analysis of arterial plaque composition and stability from CT angiography images. This system is best suited for precise patient stratification in atherosclerosis, optimizing treatment decisions by visualizing and measuring plaque characteristics, and deriving FFRct for comprehensive cardiovascular risk assessment.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	physIQ Heart Rhythm and Respiratory Module	ElucidVivo A.3
Pricing	Contact for pricing	Unknown
Deployment	Cloud-based platform	Cloud and on-premise secure deployment.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

physIQ Heart Rhythm and Respiratory Module

Tool A (physIQ) focuses on continuous data collection from wearable biosensors, with patient tools for data submission via phone apps and clinician dashboards for monitoring. The use of pre-kitted mobile devices in 'kiosk mode' suggests a streamlined and simplified patient experience for data collection.

Clinical Value

ElucidVivo A.3

Tool B (ElucidVivo A.3) provides highly precise, quantitative analysis of arterial plaque composition and stability from CT angiography, validated against ground-truth histology, and derives fractional flow reserve (FFRct). This offers profound and predictive clinical insights for atherosclerosis patient stratification and treatment optimization, directly impacting decisions to prevent major cardiovascular events.

Pricing & Value

Tie

Both tools explicitly state 'contact for pricing,' indicating a lack of public transparency regarding their cost. While Tool B mentions potential pricing models like annual licensing or subscription based on cath lab volume, specific pricing details are not available for either, making a comparative value assessment impossible.

Enterprise Readiness

physIQ Heart Rhythm and Respiratory Module

Tool A (physIQ) explicitly states it is an 'industry-leading, enterprise-ready cloud platform' and confirms BAA and HIPAA compliance, alongside FDA clearance and proven scalability for large global clinical trials. Tool B, while FDA-cleared and integrating with PACS/EMR/EHR, only implies BAA and HIPAA compliance, and some search results indicate these are 'Unknown'.

Innovation

ElucidVivo A.3

While Tool A (physIQ) is innovative with personalized physiology analytics and continuous monitoring for early decompensation, Tool B (ElucidVivo A.3) demonstrates greater innovation. Its unique capability to quantitatively analyze arterial plaque composition and stability, validated against ground-truth histology, and to derive FFRct from CT angiography, offers a deeper, more predictive level of diagnostic insight for personalized atherosclerosis management.

Support & Docs

Tie

Neither the provided structured facts nor the web searches yielded specific details about dedicated support portals, comprehensive documentation, or distinct customer support offerings for either tool. Both companies provide general contact information, but no differentiating factors were found.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	physIQ Heart Rhythm and Respiratory Module	ElucidVivo A.3
Product Name	physIQ Heart Rhythm and Respiratory Module	ElucidVivo A.3
Company	physIQ	Elucid Bioimaging
Core Function	Generates unprecedented health insight using continuous wearable biosensor data and advanced analytics, focusing on heart rhythm and respiration.	AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography.
Primary Data Input	Continuous wearable biosensor data	CT angiography images
Key Analytical Focus	AI-based personalized physiology analytics, continuous wearable biosensor data collection, FDA-cleared analytics and digital biomarkers, learns individual patient baseline, detects subtle physiological changes and early signs of decompensation, calculates heart rate and heart rate variability, detects atrial fibrillation, determines respiration rate.	AI-powered quantitative analysis of arterial plaque (Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications), visualization of lesion-level plaque composition, 3D visualization of highlighted vessels, rotatable curved MPR vessel views and cross-sections, derives fractional flow reserve (FFRct).
Specialties Supported	Cardiology, Critical Care, Pulmonology	Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring physIQ Heart Rhythm and Respiratory Module and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the type of data these tools analyze?

physIQ Heart Rhythm and Respiratory Module analyzes continuous wearable biosensor data to generate personalized physiological insights, including heart rate, heart rate variability, and respiration rate. In contrast, ElucidVivo A.3 performs quantitative analysis of arterial plaque composition and stability from CT angiography images.

How do these tools assist physicians in patient management for cardiovascular conditions?

physIQ assists by continuously monitoring patients to detect subtle physiological changes and early signs of decompensation, including atrial fibrillation. ElucidVivo A.3 aids in atherosclerosis patient stratification and optimizes treatment decisions by providing detailed visualization and measurement of plaque characteristics, validated against histology.

What specific cardiac conditions or aspects of cardiovascular health do these tools address?

physIQ focuses on heart rhythm and respiratory rate, detecting conditions like atrial fibrillation and early signs of physiological decompensation. ElucidVivo A.3 specializes in the quantitative analysis of arterial plaque composition and stability, which is crucial for managing atherosclerosis.

What kind of insights do these tools provide to inform clinical decisions?

physIQ provides AI-based personalized physiology analytics, learning individual patient baselines to detect subtle changes in heart rate, heart rate variability, and respiration rate. ElucidVivo A.3 objectively quantifies plaque components like Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, offering lesion-level plaque composition visualization and deriving fractional flow reserve (FFRct).